Effects of empagliflozin and its combination with docetaxel on LNCaP and DU- 145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis

Ahmet Cumaoğlu(Erciyes University), Mükerrem Betül Yerer(Erciyes University)
Naunyn-Schmiedeberg s Archives of Pharmacology
April 14, 2025
Cited by 0


Related Papers